Grant Wishart

1.2k total citations
29 papers, 633 citations indexed

About

Grant Wishart is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Grant Wishart has authored 29 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Organic Chemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Grant Wishart's work include Receptor Mechanisms and Signaling (7 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Cannabis and Cannabinoid Research (5 papers). Grant Wishart is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Cannabis and Cannabinoid Research (5 papers). Grant Wishart collaborates with scholars based in United Kingdom, United States and Germany. Grant Wishart's co-authors include Elizabeth M. Moir, Zoran Ranković, Craig Jamieson, John K. Clark, David H. Bremner, Andrea K. Houghton, Omar Aziz, Marieke Lamers, Andrew J. Stott and Dawn Yates and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Grant Wishart

29 papers receiving 600 citations

Peers

Grant Wishart
Elizabeth M. Moir United Kingdom
Brian A. McKittrick United States
Gee‐Hong Kuo United States
John S. Major United Kingdom
Ligaya M. Simpkins United States
Joannes T. M. Linders United States
Terry W. Schorn United States
George Chiu United States
Evgeny Kiselev United States
M. Ohno Japan
Elizabeth M. Moir United Kingdom
Grant Wishart
Citations per year, relative to Grant Wishart Grant Wishart (= 1×) peers Elizabeth M. Moir

Countries citing papers authored by Grant Wishart

Since Specialization
Citations

This map shows the geographic impact of Grant Wishart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Wishart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Wishart more than expected).

Fields of papers citing papers by Grant Wishart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant Wishart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Wishart. The network helps show where Grant Wishart may publish in the future.

Co-authorship network of co-authors of Grant Wishart

This figure shows the co-authorship network connecting the top 25 collaborators of Grant Wishart. A scholar is included among the top collaborators of Grant Wishart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant Wishart. Grant Wishart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, David, Mark G. Bock, John R. Doedens, et al.. (2022). Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors. ACS Medicinal Chemistry Letters. 13(8). 1321–1328. 15 indexed citations
2.
Luckhurst, Christopher A., Omar Aziz, Vahri Beaumont, et al.. (2018). Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(1). 83–88. 38 indexed citations
3.
Luckhurst, Christopher A., Perla Breccia, Andrew J. Stott, et al.. (2015). Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors. ACS Medicinal Chemistry Letters. 7(1). 34–39. 42 indexed citations
4.
Zhou, Gang, Pauline C. Ting, Grant Wishart, et al.. (2014). Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(7). 1790–1794. 11 indexed citations
5.
Adam, Julia M., John K. Clark, Takao Kiyoi, et al.. (2012). Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(8). 2932–2937. 15 indexed citations
6.
Baker, James Α., Matilda Bingham, Angus R. Brown, et al.. (2011). Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(15). 4622–4628. 2 indexed citations
7.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2011). Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(7). 2034–2039. 3 indexed citations
8.
Kiyoi, Takao, et al.. (2011). Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions. Tetrahedron Letters. 52(27). 3417–3420. 3 indexed citations
9.
10.
Reid, Mark, Wilson Caulfield, Ola Epemolu, et al.. (2010). The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(12). 3713–3716. 6 indexed citations
11.
Morrison, Angus J., Julia M. Adam, James Α. Baker, et al.. (2010). Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor. Bioorganic & Medicinal Chemistry Letters. 21(1). 506–509. 13 indexed citations
12.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2010). The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 497–501. 6 indexed citations
13.
Moir, Elizabeth M., Phillip M. Cowley, Morag Ferguson, et al.. (2010). Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(24). 7327–7330. 16 indexed citations
14.
Palin, Ronald, John K. Clark, Louise Evans, et al.. (2009). Rapid access towards follow-up NOP receptor agonists using a knowledge based approach. Bioorganic & Medicinal Chemistry Letters. 19(22). 6441–6446. 3 indexed citations
15.
Palin, Ronald, John K. Clark, Louise Evans, et al.. (2008). Structure–activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties. Bioorganic & Medicinal Chemistry. 16(6). 2829–2851. 18 indexed citations
16.
Palin, Ronald, A. Bom, John K. Clark, et al.. (2006). Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties. Bioorganic & Medicinal Chemistry. 15(4). 1828–1847. 17 indexed citations
17.
Jamieson, Craig, Elizabeth M. Moir, Zoran Ranković, & Grant Wishart. (2006). Medicinal Chemistry of hERG Optimizations: Highlights and Hang‐Ups. ChemInform. 37(46). 1 indexed citations
18.
Palin, Ronald, John K. Clark, Jean E. Cottney, et al.. (2004). Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 589–593. 10 indexed citations
19.
Selwood, David L., et al.. (2001). Solution-phase parallel synthesis of 5-carboxamido 1-benzyl-3-(3-dimethylaminopropyloxy)-1H-pyrazoles as activators of soluble guanylate cyclase with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 11(8). 1089–1092. 18 indexed citations
20.
Wishart, Grant, et al.. (1997). Modeling of the agonist binding site of serotonin human 5-HT1A, 5-HT1Dα and 5-HT1Dβ receptors. European Journal of Medicinal Chemistry. 32(1). 59–69. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth M. Moir Breakdown of academic impact, for papers by Brian A. McKittrick Breakdown of academic impact, for papers by Gee‐Hong Kuo Breakdown of academic impact, for papers by John S. Major Breakdown of academic impact, for papers by Ligaya M. Simpkins Breakdown of academic impact, for papers by Joannes T. M. Linders Breakdown of academic impact, for papers by Terry W. Schorn Breakdown of academic impact, for papers by George Chiu Breakdown of academic impact, for papers by Evgeny Kiselev Breakdown of academic impact, for papers by M. Ohno
Rankless by CCL
2026